Tryp Therapeutics Inc (TRYPF) Corporate Presentation

Corporate Presentation Fall 2021 THE RIGHT PEOPLE AT THE RIGHT TIME Greg McKee Chairman and CEO 25֔ years experience as CEO leading publicly traded biopharma companies and other organizations Jim Gilligan, Ph.D. President and CSO 35֔ years of experience including R&D, clinical development, regulatory affairs, and manufacturing Luke Hayes Chief Financial Officer 20֔ years of life science experience in finance, venture capital, business development, and technology transfer Tom D’Orazio Chief Operating Officer Extensive experience developing and commercializing vaccines, drugs, radiopharmaceuticals, and biologics Peter Guzzo, Ph.D. VP, Drug Development 25֔ years of experience developing innovative therapeutics for diseases with limited treatment options Larry Norder VP, Manufacturing 30֔ years of experience in the pharmaceutical industry including manufacturing and drug delivery Joy Willis Director, Investor Relations Prior experience as an Analyst at Solebury Trout, a leading investor relations firm for life science companies 26